<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药智网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-05T20:21:43+08:00</updated>
  <subtitle>一个有态度、有深度、有温度的医药健康领域融媒体平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020盘点：中国2类「改良型新药」分析，江苏恒瑞、南京圣和…</title>
    <updated>2021-01-05T16:53:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/EmZFgBTRuhUk4q4XZTmhdw</id>
    <link href="https://mp.weixin.qq.com/s/EmZFgBTRuhUk4q4XZTmhdw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>如何抢滩中药创新药，在国际市场施展“中国功夫”？</title>
    <updated>2021-01-05T16:53:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/-74Eg6eFt4OeSKkLQDOWig</id>
    <link href="https://mp.weixin.qq.com/s/-74Eg6eFt4OeSKkLQDOWig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>十大外企发布28款医保准入产品，谁是王者？</title>
    <updated>2021-01-05T16:53:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/iq_sVgOGw7OZ7PSUrcO8bg</id>
    <link href="https://mp.weixin.qq.com/s/iq_sVgOGw7OZ7PSUrcO8bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家医保局督促各省紧盯法院、税务、媒体！药企小心成负面典型！</title>
    <updated>2021-01-05T16:53:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/X3SWlDshje6heQOBjtfLtw</id>
    <link href="https://mp.weixin.qq.com/s/X3SWlDshje6heQOBjtfLtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点：生物医药跌幅top10，君实生物、复旦张江等知名企业无奈上榜</title>
    <updated>2021-01-04T17:08:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/kGNAxSNWQJrNrekzOtUgoA</id>
    <link href="https://mp.weixin.qq.com/s/kGNAxSNWQJrNrekzOtUgoA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点：国内医药、医疗界最具影响力十大人物</title>
    <updated>2021-01-04T17:08:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/flU2Ss7yw0NlHr6QxeZ8_w</id>
    <link href="https://mp.weixin.qq.com/s/flU2Ss7yw0NlHr6QxeZ8_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗不良反应等安全性，临床前如何评价呢？</title>
    <updated>2021-01-04T17:08:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/GJLI0RNNIkjeIX43yCTXjw</id>
    <link href="https://mp.weixin.qq.com/s/GJLI0RNNIkjeIX43yCTXjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>28位药企董事长，离职（附名单）</title>
    <updated>2021-01-04T17:08:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/FcPUJFfscBkKpaKWdgjBhQ</id>
    <link href="https://mp.weixin.qq.com/s/FcPUJFfscBkKpaKWdgjBhQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国企医院改制再遇波折，三年缓冲大限迫近，冲刺阶段如何破局？</title>
    <updated>2021-01-04T17:08:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/K8D-SO7ip3Hu664GLFweVw</id>
    <link href="https://mp.weixin.qq.com/s/K8D-SO7ip3Hu664GLFweVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点：828个国产1类创新药申请获CDE受理！23个突破性受理号，204个申请纳入优先审评…</title>
    <updated>2021-01-02T17:23:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/WE4H83FtVUQe6Z-c8mZeLQ</id>
    <link href="https://mp.weixin.qq.com/s/WE4H83FtVUQe6Z-c8mZeLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专家新年寄语温暖来袭，2021行业趋势，大咖怎么看？</title>
    <updated>2020-12-31T17:47:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/1AL-N2bITrhcDunoZT4SNg</id>
    <link href="https://mp.weixin.qq.com/s/1AL-N2bITrhcDunoZT4SNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021一路有你，不惧风雨，药智网祝大家新年快乐</title>
    <updated>2020-12-31T17:47:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/ux0Wqah4P6sBZ80cmVFILQ</id>
    <link href="https://mp.weixin.qq.com/s/ux0Wqah4P6sBZ80cmVFILQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>超级重磅!国药新冠疫苗国内已附条件上市！</title>
    <updated>2020-12-31T11:00:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/2Wb8qumxl3GsVacAFLpgcg</id>
    <link href="https://mp.weixin.qq.com/s/2Wb8qumxl3GsVacAFLpgcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TO B或TO C终究还是要TO SUCCESS，药智传媒帮您搞定</title>
    <updated>2020-12-31T11:00:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/zsyIGU9VxAt1pPCd--IPDA</id>
    <link href="https://mp.weixin.qq.com/s/zsyIGU9VxAt1pPCd--IPDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点：生物医药AH股十大“破发”公司</title>
    <updated>2020-12-30T15:48:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/PCK870ihTAMfz12ahzpHwA</id>
    <link href="https://mp.weixin.qq.com/s/PCK870ihTAMfz12ahzpHwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！12部委联合印发57个国家重点监测短缺药清单</title>
    <updated>2020-12-30T15:48:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/h24IRmd0SKdsZHdyj8UwCA</id>
    <link href="https://mp.weixin.qq.com/s/h24IRmd0SKdsZHdyj8UwCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国药中生官宣: 新冠病毒灭活疫苗有效率79.34%，已递交附条件上市申请！</title>
    <updated>2020-12-30T15:48:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/fwKuO_SPsC6gPRtDQWKdZQ</id>
    <link href="https://mp.weixin.qq.com/s/fwKuO_SPsC6gPRtDQWKdZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>平底两声雷，“23价肺炎疫苗终止”+“2020业绩预告”导致“力生制药”近乎跌停？</title>
    <updated>2020-12-30T15:48:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/WImNQMm0nVYyGW68jzLhmQ</id>
    <link href="https://mp.weixin.qq.com/s/WImNQMm0nVYyGW68jzLhmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国产创新药来袭！另有2款印度药获批，超30款仿制药通过一致性评价</title>
    <updated>2020-12-30T15:48:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/fM2XjKYwFMii53gzcDfeIA</id>
    <link href="https://mp.weixin.qq.com/s/fM2XjKYwFMii53gzcDfeIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020医保目录分析：超700个药品支付受限；3款重磅抗癌药未能续约；新基、正大天晴...</title>
    <updated>2020-12-29T17:25:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/a1K2EqRjXB-7Jv6PHH5ybA</id>
    <link href="https://mp.weixin.qq.com/s/a1K2EqRjXB-7Jv6PHH5ybA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>